Profil
Peder Møller Andersen currently works at Biosergen AB, as Chief Medical Officer from 2024.
Dr. Andersen also formerly worked at Biosergen AS, as Chief Executive Officer & Director, Forward Pharma GmbH, as Managing Director from 2009 to 2016, Astion Pharma A, as Vice President-Clinical Development from 2010 to 2012, and Forward Pharma A, as Chief Operating Officer in 2017.
Dr. Andersen received his doctorate degree in 1981 from the University of Copenhagen.
Postes actifs de Peder Andersen
| Sociétés | Poste | Début |
|---|---|---|
| BIOSERGEN AB | Directeur Technique/Scientifique/R&D | 31/01/2024 |
Anciens postes connus de Peder Andersen
| Sociétés | Poste | Fin |
|---|---|---|
| FORWARD PHARMA A/S | Directeur Général | 01/03/2017 |
Forward Pharma GmbH
Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Directeur Général | 01/01/2016 |
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/2012 |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Directeur Général | - |
Formation de Peder Andersen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Health Technology |
Forward Pharma GmbH
Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Biosergen AB
Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
















